BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Nowacka M, Kaźmierczak D, Andrzejewska M, Rusek D, Brązert M, Brązert J, Nowicki M, Januchowski R. Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development. Int J Mol Sci 2018;20:E54. [PMID: 30583585 DOI: 10.3390/ijms20010054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun C, Ma S, Chen Y, Kim NH, Kailas S, Wang Y, Gu W, Chen Y, Tuason JPW, Bhan C, Manem N, Huang Y, Cheng C, Zhou Z, Zhou Q, Zhu Y. Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. Front Oncol 2022;12:843880. [DOI: 10.3389/fonc.2022.843880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Gupta P, Miller A, Olayanju A, Madhuri TK, Velliou E. A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations-Does One Model Type Fit All? Cancers (Basel) 2022;14:1274. [PMID: 35267582 DOI: 10.3390/cancers14051274] [Reference Citation Analysis]
3 Świerczewska M, Sterzyńska K, Wojtowicz K, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. Int J Mol Sci 2019;20:E2053. [PMID: 31027318 DOI: 10.3390/ijms20082053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Leal-egaña A, Balland M, Boccaccini AR. Re-engineering Artificial Neoplastic Milieus: Taking Lessons from Mechano- and Topobiology. Trends in Biotechnology 2020;38:142-53. [DOI: 10.1016/j.tibtech.2019.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Nielsen C. [Relaxing of unity and membership democracy in the Danish Nursing Council]. Sygeplejersken. 1980;80:9. [PMID: 6899543 DOI: 10.1002/jcp.29059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
6 Perez VM, Kearney JF, Yeh JJ. The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies. Front Oncol 2021;11:751311. [PMID: 34692532 DOI: 10.3389/fonc.2021.751311] [Reference Citation Analysis]
7 Wojtowicz K, Sterzyńska K, Świerczewska M, Nowicki M, Zabel M, Januchowski R. Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs. Int J Mol Sci 2021;22:4243. [PMID: 33921897 DOI: 10.3390/ijms22084243] [Reference Citation Analysis]
8 Sterzyńska K, Kaźmierczak D, Klejewski A, Świerczewska M, Wojtowicz K, Nowacka M, Brązert J, Nowicki M, Januchowski R. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. Int J Mol Sci 2019;20:E3927. [PMID: 31412536 DOI: 10.3390/ijms20163927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Moreira AM, Ferreira RM, Carneiro P, Figueiredo J, Osório H, Barbosa J, Preto J, Pinto-do-ó P, Carneiro F, Seruca R. Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression. Front Mol Biosci 2022;9:818552. [DOI: 10.3389/fmolb.2022.818552] [Reference Citation Analysis]
10 Yang F, Zhao Z, Cai S, Ling L, Hong L, Tao L, Wang Q. Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer. Front Oncol 2020;10:576565. [PMID: 33680916 DOI: 10.3389/fonc.2020.576565] [Reference Citation Analysis]
11 Kazmierczak D, Jopek K, Sterzynska K, Ginter-Matuszewska B, Nowicki M, Rucinski M, Januchowski R. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines. Int J Mol Sci 2020;21:E2619. [PMID: 32283808 DOI: 10.3390/ijms21072619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kazmierczak D, Jopek K, Sterzynska K, Nowicki M, Rucinski M, Januchowski R. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines. Int J Mol Sci 2022;23:526. [PMID: 35008952 DOI: 10.3390/ijms23010526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu S, Xu H, Wang W, Li S, Li H, Li T, Zhang W, Yu X, Liu L. The role of collagen in cancer: from bench to bedside. J Transl Med 2019;17:309. [PMID: 31521169 DOI: 10.1186/s12967-019-2058-1] [Cited by in Crossref: 116] [Cited by in F6Publishing: 122] [Article Influence: 38.7] [Reference Citation Analysis]
14 Xiao W, Shen Y, Xu Y. LOXG473A induces the formation of osteoclasts in RAW264.7 cells via IL-6/JAK2/STAT3 signaling. Exp Cell Res 2021;409:112890. [PMID: 34695437 DOI: 10.1016/j.yexcr.2021.112890] [Reference Citation Analysis]
15 Yee C, Dickson K, Muntasir MN, Ma Y, Marsh DJ. Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine. Front Bioeng Biotechnol 2022;10:836984. [DOI: 10.3389/fbioe.2022.836984] [Reference Citation Analysis]
16 Nowacka M, Ginter-Matuszewska B, Świerczewska M, Sterzyńska K, Nowicki M, Januchowski R. Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model. Int J Mol Sci 2022;23:3036. [PMID: 35328460 DOI: 10.3390/ijms23063036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Foroughi pour A, White BS, Park J, Sheridan TB, Chuang JH. Deep learning features encode interpretable morphologies within histological images. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13541-2] [Reference Citation Analysis]
18 Jary M, Hasanova R, Vienot A, Asgarov K, Loyon R, Tirole C, Bouard A, Orillard E, Klajer E, Kim S, Viot J, Colle E, Adotevi O, Bouché O, Lecomte T, Borg C, Feugeas JP. Molecular description of ANGPT2 associated colorectal carcinoma. Int J Cancer 2020;147:2007-18. [PMID: 32222972 DOI: 10.1002/ijc.32993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kumari S, Patro ARK, Mishra B, Jena SK, Singh S. Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population. Diagnostics 2022;12:53. [DOI: 10.3390/diagnostics12010053] [Reference Citation Analysis]
20 Nowacka M, Sterzynska K, Andrzejewska M, Nowicki M, Januchowski R. Drug resistance evaluation in novel 3D in vitro model. Biomed Pharmacother 2021;138:111536. [PMID: 34311534 DOI: 10.1016/j.biopha.2021.111536] [Reference Citation Analysis]
21 Ye L, Yin G, Jiang M, Tu B, Li Z, Wang Y. Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling. Integr Cancer Ther 2021;20:1534735421991217. [PMID: 33724059 DOI: 10.1177/1534735421991217] [Reference Citation Analysis]